Immunohistochemistry, Quality Control, and Principles of Validation in the Central Nervous System

Area of Science:

• Histopathology
• Immunohistochemistry
• Central Nervous System Diagnostics

Background:

• Hematoxylin and eosin (H&E) staining is a cornerstone of histological diagnosis.
• Immunohistochemistry (IHC) plays an indispensable role in diagnosing central nervous system disorders.
• IHC utilizes immunological and chemical reactions to detect specific antigens within tissue sections.

Purpose of the Study:

• To provide a comprehensive review of immunohistochemistry (IHC) in the context of central nervous system diagnostics.
• To elucidate the critical phases involved in IHC procedures.
• To emphasize the importance of quality control and validation in IHC.

Main Methods:

• Review of preanalytic, analytic, and postanalytic phases of immunohistochemistry.
• Discussion of quality control principles.
• Examination of validation strategies for IHC techniques.

Main Results:

• Detailed examination of the entire workflow of immunohistochemistry, from sample preparation to final interpretation.
• Identification of key factors influencing the accuracy and reliability of IHC results.
• Highlighting the necessity of rigorous quality assurance protocols.

Conclusions:

• Immunohistochemistry is a powerful tool for CNS pathology, requiring careful attention to all procedural phases.
• Adherence to quality control and validation ensures the diagnostic integrity of IHC.
• Optimizing IHC techniques enhances diagnostic accuracy and patient care in neurology.